RecruitingPhase 2NCT07340411

Effect of Chinese Herbal Medicine Nasal Irrigation on the Postoperative Care of Chronic Rhinosinusitis


Sponsor

Taichung Veterans General Hospital

Enrollment

80 participants

Start Date

Jul 5, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Investigators tried to evaluate the efficacy and safety of Chinese herbal medicine nasal irrigation as an adjuvant therapy after FESS.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria1

  • \. Patients with chronic rhinosinusitis who failed medical treatment 2.Patients underwent bilateral primary functional endoscopic sinus surgery.

Exclusion Criteria1

  • \. Patients with a history of immunodeficiency 2.Patients with a history of sinus surgery 3.Patients who receiving antibiotic treatment within a week before functional endoscopic sinus surgery 4.Patients with a pathological diagnosis of fungal sinusitis 5.Patients with a pathological diagnosis of sinonasal tumor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGChinese herbal medicine Powder

The bilateral nasal cavity was irrigated by using a NeilMed® SINUS RINSE™ Squeeze Bottle containing 240ml of Chinese herbal medicine solution twice a day for 2 months.

DRUGSalt Powder

The bilateral nasal cavity was irrigated by using a NeilMed® SINUS RINSE™ Squeeze Bottle containing 240ml of of normal saline twice a day for 2 months.


Locations(1)

Taichung Veterans General Hospital

Taichung, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07340411


Related Trials